Trial Profile
Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2018
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Adenomyosis
- Focus Therapeutic Use
- 08 Feb 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to IND issues.
- 02 Nov 2017 New trial record